Kyverna Therapeutics, Inc. (KYTX) at a glance

Kyverna Therapeutics, Inc. (KYTX) is a small-cap Healthcare company. It trades at $8.46, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 41/100 overall. Its strongest dimension is Value (53/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$8.46

Market cap

$489.7M

P/E ratio

n/a

Dividend yield

None

Beta

1.96

52-week range

$3.55 to $13.67